Bariatric patient: what is the key to success? Case from practice
https://doi.org/10.14341/omet12983
Abstract
Surgical treatment in the scope of laparoscopic gastric bypass for morbid obesity and type 2 diabetes mellitus (DM 2) with careful preoperative preparation, a gradual expansion of the diet with the obligatory observance of the recommendations of a nutritionist on the balance of micro- and macronutrients, a gradual increase in the amount of available physical activity in the postoperative period allows not only significantly reduce body weight, but also achieve compensation for obesity-related diseases. The expected development of micro- and macronutrient deficiencies requires an active search for and compensation for these conditions both at the pre- and postoperative stages. The development of postbariatric hypoglycemia confirms the need to comply with dietary recommendations not only at the stage of conservative treatment of obesity and DM 2, but also, no less important, after bariatric surgery.
About the Authors
E. V. Ershova
Endocrinology Research Centre
Russian Federation
Russian Federation
Ekaterina V. Ershova, MD, PhD
11 Dm.Ulyanova street, 117036 Moscow
N. V. Frolkova
Endocrinology Research Centre
Russian Federation
Russian Federation
Nadezhda V. Frolkova, MD
Moscow
K. A. Komshilova
Endocrinology Research Centre
Russian Federation
Russian Federation
Kseniya A. Komshilova, MD, PhD
Moscow
N. V. Mazurina
Endocrinology Research Centre
Russian Federation
Russian Federation
Natalya V. Mazurina, MD, PhD
Moscow
References
1. Buchwald H., Varco R. Metabolic Surgery. New York: Grune & Stratton. – 1978. – Сhap. 11
2. Kremen A, Linner J, Nelson C. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg. 1954; 140:439–444 DOI: 10.1097/00000658-195409000-00018
3. Payne J, DeWind L, Commons R. Metabolic observations in patients with jejunocolic shunts. Am J Surg. 1963; 106:273–289 DOI: 10.1016/0002-9610(63)90017-5
4. Mason E., Ito C. Gastric bypass in obesity. Surg Clinics North Am. 1967; 47(6):1345–51. DOI: 10.1016/s0039-6109(16)38384-0
5. Pories W., MacDonald K., Flickinger E. et al. Is type II diabetes mellitus (NIDDM) a surgical disease? Ann Surg. 1992; 215:633–42 DOI: 10.1097/00000658-199206000-00010
6. Pories W., Swanson M., MacDonald K. et al. Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes mellitus. Ann Surg. 1995; 222:339–52 DOI: 10.1097/00000658-199509000-00011
7. Laferrere B., Heshka S., Wang K. et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care. 2007; 30:1709–16 DOI: 10.2337/dc06-1549
8. Ershova EV. Obmen gljukozy, lipidov i produkcija inkretinov u pacientov s ozhireniem i saharnym diabetom 2 tipa posle biliopankreaticheskogo shuntirovanija [dissertation]. Moscow; 2016. (In Russ.)].
9. Buchwald H., Avidor Y., Braunwald E. et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004; 292: 1724-37 DOI: 10.1001/jama.292.14.1724
10. Buchwald H., Estok R., Fahrbach K. et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007; 142: 621-32 DOI: 10.1016/j.surg.2007.07.018
11. Buchwald H., Estok R., Fahrbach K. et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009; 122: 249-61 DOI: 10.1016/j.amjmed.2008.09.041
12. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012; 366(17):1577–85 DOI: 10.1056/NEJMoa1200111
13. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med. 2017; 376(7):641–651 DOI: 10.1056/NEJMoa1600869
14. Khorgami Z, Shoar S, Saber AA, et al. Outcomes of bariatric surgery versus medical management for type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Obes Surg. 2019; 29(3):964–974 DOI: 10.1007/s11695-018-3552-x
15. Aminian A. Bariatric procedure selection in patients with type 2 diabetes: choice between Roux-en-Y gastric bypass or sleeve gastrectomy. Surg Obes Relat Dis. 2020; 16(2):332–339 DOI: 10.1016/j.soard.2019.11.013
16. Ikramuddin S, Korner J, Lee W-J, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study randomized clinical trial. JAMA. 2013; 309:2240–49 DOI: 10.1001/jama.2013.5835
17. Ikramuddin S, Korner J, Lee W-J, et al. Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study. JAMA. 2018; 319(3):266-278. doi: 10.1001/jama.2017.20813 DOI: 10.1001/jama.2017.20813
18. Mechanick J., Apovian С., Brethauer S. еt al. Clinical Practice Guidelines For The Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update. Endocr Pract. 2019; 25(12):1346-59. doi: 10.4158/GL-2019-0406 DOI: 10.1002/oby.22719
19. Brix JM, Kopp HP, Höllerl F et al. Frequency of Hypoglycaemia after Different Bariatric Surgical Procedures. Obes Facts. 2019; 12(4):397-406. doi:10.1159/000493735 DOI: 10.1159/000493735
20. Salehi M, Vella A, McLaughlin, et al. Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies. J Clin Endocrinol Metab. 2018; 103(8):2815-26. doi.org/10.1210/jc.2018-00528 DOI: 10.1210/jc.2018-00528
21. Kim EI, Ershova EV, Mazurina NV, Komshilova KA. A view at postbariatric hypoglycemia by endocrinologist. Obesity and metabolism. 2022;18(4):471-483. (In Russ.)]. doi: https://doi.org/10.14341/omet12785
22. Dedov II, Shestakova MV, Mayorov AYu, et al. Standards of specialized diabetes care. Diabetes Mellitus. 2021;24(S1):1-235 (In Russ.)]. doi: https://doi.org/10.14341/DM12802
23. Tsur A, Machtinger R, Segal-Lieberman G, et al. Obesity, bariatric surgery and future fertility. Harefuah. 2014;153(8):478-81
24. Guelinckx I, Devlieger R, Vansant G. Reproductive outcome after bariatric surgery: a critical review. Hum Reprod Update. 2009; 15(2):189-201 DOI: 10.1093/humupd/dmn057
25. Kellogg TA, Bantle JP, Leslie DB, et al. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis. 2008; 4(4):492-499. https://doi.org/10.1016/j.soard.2008.05.005 DOI: 10.1016/j.soard.2008.05.005
26. Botros N, Rijnaarts I, Brandts H, et al. Effect of carbohydrate restriction in patients with hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. Obes Surg. 2014; 24(11):1850-1855. https://doi.org/10.1007/s11695-014-1319-6
27. Goldfine AB, Mun EC, Devine E, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab. 2007; 92(12):4678-4685. https://doi.org/10.1210/jc.2007-0918
Supplementary files
|
|
1. Figure 1. Gastric bypass surgery (adapted from Use of bariatric surgery in patients with type 2 diabetes: help to the practitioner Ershova E.V., Troshina E.A.) | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(153KB)
|
Indexing metadata ▾ | |
|
|
2. Figure 2. A. Patient M., before surgery, weight 139 kg. B. Patient M., 6 months after gastric bypass, weight 94 kg | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(210KB)
|
Indexing metadata ▾ | |
|
|
3. Figure 3. A. Patient M., before surgery, weight 139 kg. B. Patient M., 12 months after gastric bypass, weight 83 kg | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(262KB)
|
Indexing metadata ▾ | |
|
|
4. Figure 4. A. Patient M., before surgery, weight 139 kg. B. Patient M., 1.5 years after gastric bypass, weight 69 kg | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(213KB)
|
Indexing metadata ▾ | |
|
|
5. Figure 5. A. Patient M., before surgery, weight 139 kg. B., C. Patient M., 2 years after gastric bypass, weight 63.5 kg | |
| Subject | ||
| Type | Исследовательские инструменты | |
View
(381KB)
|
Indexing metadata ▾ | |
Review
For citations:
Ershova E.V., Frolkova N.V., Komshilova K.A., Mazurina N.V. Bariatric patient: what is the key to success? Case from practice. Obesity and metabolism. 2023;20(2):163-169. (In Russ.) https://doi.org/10.14341/omet12983
Views:
917
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
